Literature DB >> 17356268

Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa.

Sakuo Yamada1, Yukiyoshi Hyo, Sachiyo Ohmori, Masanobu Ohuchi.   

Abstract

BACKGROUND: The aim of this study was to investigate the synergistic effect of ciprofloxacin (CPFX) and fosfomycin (FOM) on CPFX-resistant Pseudomonas aeruginosa strains.
METHODS: The synergistic effect was evaluated using the fractional inhibitory concentration index, acute bactericidal effect and morphological observation.
RESULTS: In the fractional inhibitory concentration index experiments, the combination of CPFX with FOM showed a synergistic effect in 20 of 74 (27.0%) strains of P. aeruginosa. From the morphological observations, it was determined that CPFX affected the outer membrane structure. CPFX combined with FOM caused striking morphological changes, resulting in bacteriolysis. A time lag experiment suggested that the addition of CPFX prior to FOM produced more pronounced bactericidal activity than the addition of FOM prior to CPFX.
CONCLUSIONS: These results indicate that the combination of CPFX with FOM induces a synergistic effect on CPFX-resistant P. aeruginosa strains. The role of CPFX is thought to be related to damage of the outer membrane, enhancing FOM penetration. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356268     DOI: 10.1159/000100811

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  13 in total

1.  Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa.

Authors:  Alexandro Rodríguez-Rojas; Alejandro Couce; Jesús Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

Review 2.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

3.  Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa.

Authors:  Marisa L Winkler; Krisztina M Papp-Wallace; Andrea M Hujer; T Nicholas Domitrovic; Kristine M Hujer; Kelly N Hurless; Marion Tuohy; Geraldine Hall; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

4.  Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.

Authors:  Antonia C Kastoris; Petros I Rafailidis; Evridiki K Vouloumanou; Ioannis D Gkegkes; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2010-02-26       Impact factor: 2.953

5.  Antimicrobial effects of Burow's solution on Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Yukiyoshi Hyo; Sakuo Yamada; Masaki Ishimatsu; Kenji Fukutsuji; Tamotsu Harada
Journal:  Med Mol Morphol       Date:  2012-06-21       Impact factor: 2.309

6.  Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycin.

Authors:  Marina Borisova; Jonathan Gisin; Christoph Mayer
Journal:  Microb Drug Resist       Date:  2014-05-12       Impact factor: 3.431

7.  Thickening of the cell wall in macrolide-resistant Staphylococcus aureus.

Authors:  Yukiyoshi Hyo; Sakuo Yamada; Kenji Fukutsuji; Tamotsu Harada
Journal:  Med Mol Morphol       Date:  2013-02-14       Impact factor: 2.309

Review 8.  Fosfomycin and nitrofurantoin: classic antibiotics and perspectives.

Authors:  Cristiane Dos Santos; Lucas Souza Dos Santos; Octávio Luiz Franco
Journal:  J Antibiot (Tokyo)       Date:  2021-07-09       Impact factor: 2.649

Review 9.  Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Authors:  Anneke Corinne Dijkmans; Natalia Veneranda Ortiz Zacarías; Jacobus Burggraaf; Johan Willem Mouton; Erik Bert Wilms; Cees van Nieuwkoop; Daniel Johannes Touw; Jasper Stevens; Ingrid Maria Catharina Kamerling
Journal:  Antibiotics (Basel)       Date:  2017-10-31

10.  In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius.

Authors:  Matthew DiCicco; Suresh Neethirajan; J Scott Weese; Ameet Singh
Journal:  BMC Microbiol       Date:  2014-05-19       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.